Clinical Trials Insight: 700028885

Trial Profile

Clinical Trials Insight: 700028885

Phase of Trial: Phase II

Latest Information Update: 14 May 2008

At a glance

  • Drugs Auriclosene (Primary)
  • Indications Staphylococcal infections
  • Focus Therapeutic Use
  • Sponsors NovaBay Pharmaceuticals
  • Most Recent Events

    • 14 May 2008 Results expected to be announced in late May 2008.
    • 14 May 2008 Status changed from initiated to completed, according to a NovaBay media release.
    • 11 Mar 2008 Status changed from planning to initiated, from a NovaBay media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top